|
NDUFS8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.01740000155471E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12850000000275E-06 |
| Normal-vs-Stage2 |
1.37759999996323E-06 |
| Normal-vs-Stage3 |
9.09079999944495E-07 |
| Normal-vs-Stage4 |
3.5533000000032E-05 |
| Stage1-vs-Stage2 |
1.975720E-02 |
| Stage1-vs-Stage3 |
3.472800E-01 |
| Stage1-vs-Stage4 |
9.018800E-01 |
| Stage2-vs-Stage3 |
8.955600E-02 |
| Stage2-vs-Stage4 |
3.371700E-02 |
| Stage3-vs-Stage4 |
5.037400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89799999994467E-06 |
| Normal-vs-AfricanAmerican |
2.444400E-03 |
| Normal-vs-Asian |
7.221800E-04 |
| Caucasian-vs-AfricanAmerican |
9.539600E-01 |
| Caucasian-vs-Asian |
6.706200E-01 |
| AfricanAmerican-vs-Asian |
8.200400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77789999950195E-07 |
| Normal-vs-Female |
1.09819999982719E-07 |
| Male-vs-Female |
5.522800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.08239999999194E-05 |
| Normal-vs-Age(41-60Yrs) |
4.18019999948172E-07 |
| Normal-vs-Age(61-80Yrs) |
3.82309999991115E-07 |
| Normal-vs-Age(81-100Yrs) |
6.412400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.903400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.436410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.651000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.952600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.783600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.377400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.048390E-01 |
| Classical-VS-Follicular |
1.10750000004156E-06 |
| Classical-VS-Other |
7.402800E-01 |
| Classical-VS-Normal |
2.205900E-04 |
| Tall-VS-Follicular |
9.581900E-02 |
| Tall-VS-Other |
6.879400E-01 |
| Tall-VS-Normal |
4.756300E-04 |
| Follicular-VS-Other |
2.003600E-01 |
| Follicular-VS-Normal |
2.39300024240663E-10 |
| Other-VS-Normal |
8.343600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63199997960106E-09 |
| Normal-vs-N1 |
3.784500E-04 |
| N0-vs-N1 |
2.960600E-01 |
|
|
